BG104346A - Alhpa-hydroxy, -amino, and -halo derivatives of beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors - Google Patents
Alhpa-hydroxy, -amino, and -halo derivatives of beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitorsInfo
- Publication number
- BG104346A BG104346A BG104346A BG10434600A BG104346A BG 104346 A BG104346 A BG 104346A BG 104346 A BG104346 A BG 104346A BG 10434600 A BG10434600 A BG 10434600A BG 104346 A BG104346 A BG 104346A
- Authority
- BG
- Bulgaria
- Prior art keywords
- unsubstituted
- substituted
- alhpa
- beta
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7265597P | 1997-11-21 | 1997-11-21 | |
PCT/IB1998/002154 WO1999026909A2 (en) | 1997-11-21 | 1998-11-18 | Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104346A true BG104346A (en) | 2001-01-31 |
Family
ID=22108985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104346A BG104346A (en) | 1997-11-21 | 2000-04-17 | Alhpa-hydroxy, -amino, and -halo derivatives of beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors |
Country Status (24)
Country | Link |
---|---|
US (2) | US20030166687A1 (de) |
EP (1) | EP1037868B1 (de) |
JP (1) | JP2001524462A (de) |
KR (1) | KR20010032319A (de) |
CN (1) | CN1168709C (de) |
AT (1) | ATE232192T1 (de) |
AU (1) | AU763113B2 (de) |
BG (1) | BG104346A (de) |
BR (1) | BR9814699A (de) |
CA (1) | CA2310401A1 (de) |
DE (1) | DE69811273T2 (de) |
DK (1) | DK1037868T3 (de) |
EA (1) | EA003585B1 (de) |
ES (1) | ES2192349T3 (de) |
HU (1) | HUP0100812A3 (de) |
IL (1) | IL135586A0 (de) |
IS (1) | IS1954B (de) |
NO (1) | NO20002505L (de) |
NZ (1) | NZ503997A (de) |
PL (1) | PL341153A1 (de) |
PT (1) | PT1037868E (de) |
TR (1) | TR200001391T2 (de) |
UA (1) | UA66818C2 (de) |
WO (1) | WO1999026909A2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69811273T2 (de) * | 1997-11-21 | 2003-12-11 | Upjohn Co | Alpha-hydroxy, -amino und -fluoro derivate von beta-sulfonylhydroxamsäuren als matrixmetalloproteinasen-inhibitoren |
GB9927453D0 (en) * | 1999-11-19 | 2000-01-19 | Pharmacia & Upjohn Spa | Crystalline and optically active form of a-hydroxy derivatives of ›-sulfonyl acid |
JP2004509941A (ja) * | 2000-09-29 | 2004-04-02 | プロリフィクス リミテッド | Hdacインヒビターとしてのアミド結合を含むカルバミン酸化合物 |
JP4975941B2 (ja) * | 2000-09-29 | 2012-07-11 | トポターゲット ユーケー リミテッド | (e)−n−ヒドロキシ−3−(3−スルファモイル−フェニル)アクリルアミド化合物及びその治療用途 |
AU2003300076C1 (en) | 2002-12-30 | 2010-03-04 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
DE10320453A1 (de) * | 2003-05-08 | 2004-11-25 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Bioisostere von Actinonin |
JP2009519349A (ja) * | 2005-12-15 | 2009-05-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を変調する化合物 |
EP2081905B1 (de) * | 2006-07-28 | 2012-09-12 | Boehringer Ingelheim International GmbH | Sulfonyl verbindungen als cb2 rezeptor modulatoren |
CN101516839A (zh) * | 2006-09-25 | 2009-08-26 | 贝林格尔.英格海姆国际有限公司 | 调节cb2受体的化合物 |
US7539361B2 (en) * | 2006-10-05 | 2009-05-26 | Harris Corporation | Fiber optic device for measuring a parameter of interest |
DE102006049618A1 (de) * | 2006-10-20 | 2008-05-08 | Tschesche, Harald, Prof. Dr. | Triazine und Ihre Verwendung als Metalloproteinase-Inhibitoren |
JP5492092B2 (ja) * | 2007-11-07 | 2014-05-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節する化合物 |
JP5749162B2 (ja) * | 2008-07-10 | 2015-07-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節するスルホン化合物 |
BRPI0919172A2 (pt) * | 2008-09-25 | 2015-12-15 | Boehringer Ingelheim Int | compostos os quais modulam seletivamente o receptor de cb2 |
US8299103B2 (en) | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
EP2443107B1 (de) | 2009-06-16 | 2018-08-08 | Boehringer Ingelheim International GmbH | Azetidin 2 -carboxamidderivate als cb2-rezeptormodulatoren |
WO2011037795A1 (en) * | 2009-09-22 | 2011-03-31 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the cb2 receptor |
WO2011088015A1 (en) | 2010-01-15 | 2011-07-21 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
US8329735B2 (en) | 2010-03-05 | 2012-12-11 | Boehringer Ingelheim International Gmbh | Tetrazole compounds which selectively modulate the CB2 receptor |
EP2595959B1 (de) | 2010-07-22 | 2015-11-04 | Boehringer Ingelheim International GmbH | Sulfonylverbindungen zur modulierung des cb2-rezeptors |
EP2803668A1 (de) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Neuartige (Cyano-dimethyl-methyl)-isoxazole und -[1,3,4]-thiadiazole |
DK3013796T3 (da) | 2013-06-27 | 2020-03-16 | Lg Chemical Ltd | Biarylderivater som gpr120-agonister |
WO2019102488A1 (en) | 2017-11-27 | 2019-05-31 | Council Of Scientific & Industrial Research | Indole (sulfomyl) n-hydroxy benzamide derivatives as selective hdac inhibitors |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE225343T1 (de) * | 1995-12-20 | 2002-10-15 | Hoffmann La Roche | Matrix-metalloprotease inhibitoren |
EP0871439B1 (de) | 1996-01-02 | 2004-03-31 | Aventis Pharmaceuticals Inc. | Substituierte (aryl, heteroaryl, arylmethyl oder heteroarylmethyl) hydroxamisaeureverbindungen |
KR20000022532A (ko) | 1996-06-27 | 2000-04-25 | 오노 야꾸힝 고교 가부시키가이샤 | 아릴(설파이드, 설폭시드 및 설폰)유도체 및 이를 활성 성분으로 함유하는 약물 |
JP2000517297A (ja) | 1996-08-07 | 2000-12-26 | ダーウィン・ディスカバリー・リミテッド | Mmpとtnfの抑制活性を有するヒドロキサム酸誘導体およびカルボン酸誘導体 |
CN1158254C (zh) * | 1996-09-27 | 2004-07-21 | 法玛西雅厄普约翰美国公司 | 作为基质金属蛋白酶抑制剂的β-磺酰基异羟肟酸 |
JP4456183B2 (ja) * | 1997-01-22 | 2010-04-28 | アベンテイス・フアーマシユーチカルズ・インコーポレーテツド | 置換β−チオカルボン酸類 |
BR9807824A (pt) | 1997-02-07 | 2000-03-08 | Pfizer | Derivados de n-hidróxi-beta-sulfonil-propionamida e seu uso como inibidores de metaloproteinases de matriz |
EP0983257A4 (de) * | 1997-03-04 | 2001-05-02 | Monsanto Co | Aromatische sulphonyl-alpha-cycloamino-hydroxamsäure-verbindungen |
US6362183B1 (en) * | 1997-03-04 | 2002-03-26 | G. D. Searle & Company | Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
DE69811273T2 (de) * | 1997-11-21 | 2003-12-11 | Upjohn Co | Alpha-hydroxy, -amino und -fluoro derivate von beta-sulfonylhydroxamsäuren als matrixmetalloproteinasen-inhibitoren |
-
1998
- 1998-11-18 DE DE69811273T patent/DE69811273T2/de not_active Expired - Fee Related
- 1998-11-18 NZ NZ503997A patent/NZ503997A/en unknown
- 1998-11-18 IL IL13558698A patent/IL135586A0/xx unknown
- 1998-11-18 DK DK98966869T patent/DK1037868T3/da active
- 1998-11-18 UA UA2000052847A patent/UA66818C2/uk unknown
- 1998-11-18 PT PT98966869T patent/PT1037868E/pt unknown
- 1998-11-18 AU AU25405/99A patent/AU763113B2/en not_active Ceased
- 1998-11-18 ES ES98966869T patent/ES2192349T3/es not_active Expired - Lifetime
- 1998-11-18 CN CNB988106914A patent/CN1168709C/zh not_active Expired - Fee Related
- 1998-11-18 WO PCT/IB1998/002154 patent/WO1999026909A2/en not_active Application Discontinuation
- 1998-11-18 CA CA002310401A patent/CA2310401A1/en not_active Abandoned
- 1998-11-18 EP EP98966869A patent/EP1037868B1/de not_active Expired - Lifetime
- 1998-11-18 JP JP2000522069A patent/JP2001524462A/ja active Pending
- 1998-11-18 BR BR9814699-8A patent/BR9814699A/pt not_active Application Discontinuation
- 1998-11-18 KR KR1020007005530A patent/KR20010032319A/ko not_active Application Discontinuation
- 1998-11-18 AT AT98966869T patent/ATE232192T1/de not_active IP Right Cessation
- 1998-11-18 TR TR2000/01391T patent/TR200001391T2/xx unknown
- 1998-11-18 HU HU0100812A patent/HUP0100812A3/hu unknown
- 1998-11-18 US US09/530,965 patent/US20030166687A1/en not_active Abandoned
- 1998-11-18 PL PL98341153A patent/PL341153A1/xx unknown
- 1998-11-18 EA EA200000551A patent/EA003585B1/ru not_active IP Right Cessation
- 1998-11-20 US US09/196,190 patent/US6437177B1/en not_active Expired - Fee Related
-
2000
- 2000-04-17 BG BG104346A patent/BG104346A/xx unknown
- 2000-04-28 IS IS5475A patent/IS1954B/is unknown
- 2000-05-15 NO NO20002505A patent/NO20002505L/no unknown
Also Published As
Publication number | Publication date |
---|---|
BR9814699A (pt) | 2000-10-03 |
DE69811273D1 (de) | 2003-03-13 |
HUP0100812A3 (en) | 2002-11-28 |
NZ503997A (en) | 2001-09-28 |
JP2001524462A (ja) | 2001-12-04 |
KR20010032319A (ko) | 2001-04-16 |
IL135586A0 (en) | 2001-05-20 |
HUP0100812A2 (hu) | 2001-08-28 |
PT1037868E (pt) | 2003-06-30 |
US20030166687A1 (en) | 2003-09-04 |
DK1037868T3 (da) | 2003-05-12 |
AU763113B2 (en) | 2003-07-10 |
EP1037868B1 (de) | 2003-02-05 |
EP1037868A2 (de) | 2000-09-27 |
CN1278247A (zh) | 2000-12-27 |
WO1999026909A3 (en) | 1999-08-26 |
CA2310401A1 (en) | 1999-06-03 |
WO1999026909A2 (en) | 1999-06-03 |
IS1954B (is) | 2004-10-13 |
UA66818C2 (uk) | 2004-06-15 |
EA200000551A1 (ru) | 2000-10-30 |
ATE232192T1 (de) | 2003-02-15 |
IS5475A (is) | 2000-04-28 |
DE69811273T2 (de) | 2003-12-11 |
CN1168709C (zh) | 2004-09-29 |
PL341153A1 (en) | 2001-03-26 |
NO20002505D0 (no) | 2000-05-15 |
EA003585B1 (ru) | 2003-06-26 |
TR200001391T2 (tr) | 2000-11-21 |
NO20002505L (no) | 2000-06-30 |
AU2540599A (en) | 1999-06-15 |
US6437177B1 (en) | 2002-08-20 |
ES2192349T3 (es) | 2003-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG104346A (en) | Alhpa-hydroxy, -amino, and -halo derivatives of beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors | |
AU7077894A (en) | Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone | |
EA199900332A1 (ru) | β-СУЛЬФОНИЛ ГИДРОКСАМОВЫЕ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ МАТРИЧНЫХ МЕТАЛЛОПРОТЕИНАЗ | |
AU5571190A (en) | Retroviral protease inhibiting compounds | |
NO995076D0 (no) | Farmasöytisk preparat | |
AU3043192A (en) | Thiazolidine compounds, their preparation and their therapeutic uses | |
ES2093091T3 (es) | Derivado de glutation. | |
FI904449A0 (fi) | N-azasicyklo/3.3.0/oktanamider av aromatiska syror. | |
AU4713697A (en) | Process for the preparation of N-(2-(dimethylamino)ethyl)acridine-4-carboxamide | |
NO964921L (no) | Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse | |
CA2202031A1 (en) | Condensed indan derivatives and salts thereof |